Home » Topics » BioWorld Science, Hematologic

BioWorld Science, Hematologic
RSS

KalVista Pharmaceuticals patents FXIIa inhibitors

June 29, 2022

Merck & Co. identifies new FXIa and/or KLKB1 inhibitors

June 16, 2022

EHA 2022 presentations describe sickle cell disease headway and headwinds

June 14, 2022

At EHA 2022, insights into multiple reasons for marrow failure

June 13, 2022

Genentech describes von Hippel-Lindau disease tumor suppressor inhibitors

June 7, 2022

Chinese investigators patent new HIF inhibitors

May 13, 2022

Zhejiang Hisun Pharmaceutical, Hisun Accuray Therapeutics patent anticoagulants

April 12, 2022

New NFE2-related factor 2 activators described by Sanofi

April 1, 2022

Procoagulant nanoparticles as platelet surrogates for management of bleeding

March 4, 2022

China Hinye Pharmaceutical presents prodrugs of the active metabolite of clopidogrel

Feb. 28, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...